GlassScriptPhysician profile
Kristi L Francis
NPI 1295743672
$8,099.32
in general payments reported to CMS, 2019-2025
32 companies · $1,987 in 2025
The $1,987 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,021 · 2022: $1,348 · 2023: $1,876 · 2024: $1,867 · 2025: $1,987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,730.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,795.11 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $997.46 | 2021-2025 | |
| Ucb, INC. | $872.23 | 2022-2025 | Cimzia, Bimzelx |
| Pfizer INC. | $493.19 | 2021-2025 | |
| Janssen Biotech, INC. | $395.67 | 2022-2025 | Tremfya, Simponi Aria |
| Astrazeneca Pharmaceuticals LP | $306.42 | 2023-2025 | Saphnelo, Farxiga, Airsupra |
| Amgen INC. | $304.96 | 2021-2025 | Evenity, Prolia, Otezla |
| Mallinckrodt Hospital Products INC. | $279.03 | 2022-2024 | Acthar |
| Glaxosmithkline, LLC. | $261.08 | 2024-2025 | Benlysta, Trelegy Ellipta |
| Ani Pharmaceuticals, INC. | $180.22 | 2024 | Purified Cortrophin Gel |
| Lilly USA, LLC | $176.22 | 2022-2024 | Taltz, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $154.98 | 2022-2025 | |
| Atland Pharmaceuticals, LLC | $125.02 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.99 | 2021-2025 | Cyltezo, Ofev |
| Galt Pharmaceuticals, LLC | $96.54 | 2023 | Orphengesic Forte, Oravig |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $81.45 | 2023-2024 | Hyrimoz |
| Radius Health, INC. | $69.76 | 2021-2022 | |
| Dexcom, INC. | $51.65 | 2023 | Dexcom G6 Transmitter |
| Fresenius Kabi USA, LLC | $50.14 | 2023-2024 | Idacio |
| Organon LLC | $43.50 | 2023-2025 | Hadlima, Nexplanon |
| Aurinia Pharma U.S., INC. | $43.01 | 2022-2023 | Lupkynis |
| Alexion Pharmaceuticals, INC. | $26.47 | 2024 | Strensiq |
| Exact Sciences Corporation | $20.15 | 2023 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $19.95 | 2022 | |
| Genentech USA, INC. | $18.65 | 2024 | Actemra |
| Scilex Pharmaceuticals INC. | $18.00 | 2025 | |
| Tonix Medicines, INC. | $17.99 | 2025 | Tonmya |
| Pbg Puerto Rico LLC | $17.08 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.00 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $16.72 | 2022 | |
| Horizon Therapeutics Plc | $15.24 | 2022 | |
| Seqirus USA INC | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristi Francis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.